Concepedia

Peter Aspesi

PA

8

Publications

8.7K

Citations

8

H-Index

2012

Active since

Affiliations

Novartis (Switzerland)(Current)

Novartis Institutes for BioMedical Research

Harvard University

Broad Institute

Peter Aspesi is an author at Novartis (Switzerland) specializing in medicine, cell biology, and drug discovery.

ORCID

Top concepts

Publications per year

2012–2022

8

Publications

8

The Cancer Cell Line Encyclopedia enables predictive modelling of anticancer drug sensitivity

Jordi Barretina, Giordano Caponigro, Nicolas Stransky et al. · Nature · 2012 · 8.3K citations

, , +12

Nannocystin A: an Elongation Factor 1 Inhibitor from Myxobacteria with Differential Anti‐Cancer Properties

Philipp Krastel, Silvio Roggo, Markus Schirle et al. · Angewandte Chemie International Edition · 2015 · 106 citations

LXH254, a Potent and Selective ARAF-Sparing Inhibitor of BRAF and CRAF for the Treatment of MAPK-Driven Tumors

Kelli‐Ann Monaco, Scott Delach, Jing Yuan et al. · Clinical Cancer Research · 2020 · 84 citations · Full text

Phosphoinositide-signaling is one component of a robust plant defense response

Chiu‐Yueh Hung, Peter Aspesi, Melissa R. Hunter et al. · Frontiers in Plant Science · 2014 · 59 citations · Full text

, , +20

Addendum: The Cancer Cell Line Encyclopedia enables predictive modelling of anticancer drug sensitivity

Jordi Barretina, Giordano Caponigro, Nicolas Stransky et al. · Nature · 2012 · 48 citations · Full text

, , +11

Rows per page

1–5 of 8